Related Experiment Videos
Cell cycle and apoptosis deregulation in classical Hodgkin lymphomas
Maria Bai1, Alexandra Papoudou-Bai, Panagiotis Kitsoulis
1Department of Pathology, Medical Faculty, University of Ioannina, Ioannina, Greece. mbai@cc.uoi.gr
In Vivo (Athens, Greece)
|March 31, 2005
Summary
Classical Hodgkin lymphomas (cHL) show cell cycle and apoptosis deregulation in Hodgkin and Reed-Sternberg (H/RS) cells. Key pathways like NF-kappaB, p53, and Rb are altered, impacting proliferation and survival.
Area of Science:
- Oncology
- Cell Biology
- Hematology
Background:
- Classical Hodgkin lymphomas (cHL) are primarily B-cell malignancies.
- Hodgkin and Reed-Sternberg (H/RS) cells are the hallmark neoplastic cells in cHL.
- Evidence suggests dysregulation of cell cycle and apoptosis in H/RS cells.
Purpose of the Study:
- To review the molecular mechanisms underlying cell cycle and apoptosis deregulation in cHL.
- To highlight the role of specific pathways and proteins in H/RS cell survival and proliferation.
- To summarize recent findings on factors influencing these processes in cHL.
Main Methods:
- Review of existing scientific literature and studies.
- Analysis of data on molecular alterations in H/RS cells.
- Synthesis of information on cell cycle regulators, apoptosis pathways, and growth factors.
Main Results:
- H/RS cells exhibit profound disturbances in cell cycle and apoptosis regulation.
- Constitutive activation of the nuclear factor (NF)-kappaB pathway is implicated in H/RS cell proliferation and survival.
- Alterations in tumor suppressor pathways (p53, Rb, p27), overexpression of cyclins and cyclin-dependent kinases, and anti-apoptotic proteins are common.
Conclusions:
- Deregulation of cell cycle and apoptosis is a critical feature of cHL pathogenesis.
- Interleukin 13 (IL-13) and Epstein-Barr Virus (EBV) may play significant roles in H/RS cell biology.
- Understanding these molecular defects offers potential therapeutic targets for cHL.